Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
The combination of bosentan and sildenafil is commonly used to treat patients with pulmonary arterial hypertension (PAH); however, there is evidence of a significant drug interaction between these two medications. We sought to evaluate the safety and efficacy of transitioning patients with PAH from...
Main Authors: | Nathan J. Verlinden, Raymond L. Benza, Amresh Raina |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894020945523 |
Similar Items
-
Lower doses of bosentan in combination with sildenafil might be beneficial in pulmonary arterial hypertension
by: Ahmad Amin, et al.
Published: (2015-01-01) -
Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
by: Pierangelo Chinello, et al.
Published: (2011-11-01) -
Addition of Sildenafil in Patients with Pulmonary Arterial Hypertension with Inadequate Response to Bosentan Monotherapy
by: Nancy R Porhownik, et al.
Published: (2008-01-01) -
Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study
by: Raymond L. Benza, et al.
Published: (2018-01-01) -
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial
by: Carmine Dario Vizza, et al.
Published: (2017-09-01)